Literature DB >> 31290854

Recent advances in the diagnosis and management of pancreatic neuroendocrine tumours.

Andrew D Hopper1, Mustafa Jalal1, Alia Munir2.   

Abstract

The incidence of pancreatic neuroendocrine tumours (PNET) is rising mainly due to the increased use of cross-sectional imaging. Although many PNETs are asymptomatic and non-functioning, the overall 5-year survival is still less than 50%. In this article, we review the advances in diagnosis, classification and staging of PNET that have evolved with the development of new cross-sectional imaging methods and biopsy techniques. With accurate classification, evidence-based, individualised prognostic outcomes and treatments are able to be given which are also discussed.

Entities:  

Keywords:  pancreatic cancer; pancreatic disorders; pancreatic endocrine tumour; pancreatic islet cell; pancreatic tumours

Year:  2018        PMID： 31290854      PMCID： PMC6583562          DOI： 10.1136/flgastro-2018-101006

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN： 2041-4137


  48 in total

Review 1.  Neuroendocrine tumors and somatostatin: imaging techniques.

Authors:  W W de Herder; D J Kwekkeboom; R Valkema; R A Feelders; M O van Aken; S W J Lamberts; A J van der Lely; E P Krenning
Journal:  J Endocrinol Invest       Date:  2005       Impact factor: 4.256

2.  Is surgery beneficial for MEN1 patients with small (< or = 2 cm), nonfunctioning pancreaticoduodenal endocrine tumor? An analysis of 65 patients from the GTE.

Authors:  Frederic Triponez; Pierre Goudet; David Dosseh; Patrick Cougard; Catherine Bauters; Arnaud Murat; Guillaume Cadiot; Patricia Niccoli-Sire; Alain Calender; Charles A G Proye
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

3.  Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.

Authors:  J A Norton; H R Alexander; D L Fraker; D J Venzon; F Gibril; R T Jensen
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

4.  Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.

Authors:  C G Moertel; L K Kvols; M J O'Connell; J Rubin
Journal:  Cancer       Date:  1991-07-15       Impact factor: 6.860

5.  Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.

Authors:  Parsia A Vagefi; Oswaldo Razo; Vikram Deshpande; Deborah J McGrath; Gregory Y Lauwers; Sarah P Thayer; Andrew L Warshaw; Carlos Fernández-Del Castillo
Journal:  Arch Surg       Date:  2007-04

6.  Laparoscopic approach for solitary insulinoma: a multicentre study.

Authors:  A Ayav; L Bresler; L Brunaud; P Boissel
Journal:  Langenbecks Arch Surg       Date:  2004-12-18       Impact factor: 3.445

7.  Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.

Authors:  Clarisse Dromain; Thierry de Baere; Jean Lumbroso; Hubert Caillet; Agnès Laplanche; Valerie Boige; Michel Ducreux; Pierre Duvillard; Dominique Elias; Martin Schlumberger; Robert Sigal; Eric Baudin
Journal:  J Clin Oncol       Date:  2005-01-01       Impact factor: 44.544

Review 8.  Hereditary pancreatic endocrine tumours.

Authors:  N Alexakis; S Connor; P Ghaneh; M Lombard; H L Smart; J Evans; M Hughes; C J Garvey; J Vora; S Vinjamuri; R Sutton; J P Neoptolemos
Journal:  Pancreatology       Date:  2004-07-06       Impact factor: 3.996

9.  Chromogranin A: is it a useful marker of neuroendocrine tumors?

Authors:  Davide Campana; Francesca Nori; Lidya Piscitelli; Antonio Maria Morselli-Labate; Raffaele Pezzilli; Roberto Corinaldesi; Paola Tomassetti
Journal:  J Clin Oncol       Date:  2007-05-20       Impact factor: 44.544

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064
View more
  2 in total

1.  Progressing pancreaticobiliary medicine in the UK.

Authors:  Andrew R Hart; Gavin Johnson; Matthew T Huggett
Journal:  Frontline Gastroenterol       Date:  2019-06-10

Review 2.  Modelling Pancreatic Neuroendocrine Cancer: From Bench Side to Clinic.

Authors:  Alexander Ney; Gabriele Canciani; J Justin Hsuan; Stephen P Pereira
Journal:  Cancers (Basel)       Date:  2020-10-28       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.